LOGIN
Delta 9-THC has better analgesic efficacy versus placebo for neuropathic pain over 6 hours
October 2018
Delta 9-THC has better analgesic efficacy versus placebo for neuropathic pain over 6 hours
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A
A Randomized, Placebo-Controlled, Crossover Trial of Cannabis Cigarettes in Neuropathic Pain
J Pain. 2008 Jun;9(6):506-21. doi: 10.1016/j.jpain.2007.12.010Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
38 patients with neuropathic pain related to spinal cord injury and disease were administered a placebo, 3.5%, and 7% delta-9-THC in a randomized order in this crossover trial. The primary outcome was pain intensity, secondary outcomes included allodynia, heat-pain threshold, response to painful stimuli, subjective psychoactive effects, and vital signs. Patients also completed neuropsychological t...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.